Cart
sales@molnova.com
Dibenzoyl Thiamine
CAS No. 299-88-7
Dibenzoyl Thiamine( Bentiamine )
Catalog No. M21353 CAS No. 299-88-7
Dibenzoyl Thiamine a lipophilic derivative of vitamin B (thiamine) is a kind of food additive.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | Get Quote |
|
| 50MG | 27 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDibenzoyl Thiamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDibenzoyl Thiamine a lipophilic derivative of vitamin B (thiamine) is a kind of food additive.
-
DescriptionDibenzoyl Thiamine a lipophilic derivative of vitamin B (thiamine) is a kind of food additive.
-
In Vitro——
-
In Vivo——
-
SynonymsBentiamine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number299-88-7
-
Formula Weight490.6
-
Molecular FormulaC26H26N4O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:98 mg/mL (199.76 mM)
-
SMILESCC1=NC=C(C(=N1)N)CN(C=O)/C(=C(/CCOC(=O)C2=CC=CC=C2)\SC(=O)C3=CC=CC=C3)/C
-
Chemical NameBenzenecarbothioic acid S-(2-(((4-amino-2-methyl-5-pyrimidinyl)methyl)formylamino)-1-(2-(benzoyloxy)ethyl)-1-propenyl) ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Heywood R Wood JD Majeed SK.Tumorigenic and toxic effect of OS-dibenzoyl thiamine hydrochloride in prolonged dietary administration to rats.Toxicol Lett. 1985 Jul;26(1):53-8
molnova catalog
related products
-
SRI-37330
SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
-
TriGalNAc CBz
TriGalNAc CBz is a GalNAc derivative. As an ASGPR ligand, tri-GalNAc targets lysosomes in mRNA drug delivery and LYTAC studies.L-DABA hydrobromide.
-
Niraparib Tosylate M...
Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.
